Navigation Links
CuraGen Announces Presentation of Phase I Dose-Escalation Results on CR011- vcMMAE for Metastatic Melanoma
Date:10/24/2007

s contained herein. CuraGen is providing the information in this press release as of this date and assumes no obligations to update the information included in this press release or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

CRGN-P

Contacts:

Glenn Schulman, PharmD

Director of Investor Relations

gschulman@curagen.com

(888) 436-6642


'/>"/>
SOURCE CuraGen Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. CuraGen Presents Update on Clinical Development Program for Belinostat
2. CuraGen and TopoTarget Announce New Clinical Results With Belinostat to be Reported at Upcoming Major Medical Meetings
3. CuraGen Announces New Preclinical Results with Belinostat and Velafermin to be Presented at AACR Annual Meeting
4. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
5. Sygnis Pharma AG announces date for presentation of clinical results
6. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
8. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
9. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
10. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
11. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... , June 18, 2013  In a letter to ... , M.D., of Lake View, Iowa , ... receive annual influenza vaccine is neither scientifically justified nor ethically ... article in the summer issue of the Journal ... official statistics are correct, and an average of 36,000 patients ...
(Date:6/18/2013)... , June 18, 2013 The board ... LLY ) has declared a dividend for the ... outstanding common stock. The dividend is ... the close of business on August 15, 2013. ... growing portfolio of pharmaceutical products by applying the latest ...
(Date:6/18/2013)... DENVER , June 18, 2013  Healthgrades, ... evaluate, compare and connect with physicians and hospitals, ... 2013: "Lean in" When Making Healthcare Decisions to ... the best performing hospitals for maternity care, gynecologic ... the treatment of women across 15 of the ...
Breaking Medicine Technology:Mandated Flu Vaccine for Hospital Workers Ethically Questionable, Surgeon Writes 2Healthgrades Recognizes Top Hospitals in Treatment of Maternity Care, Gynecologic Surgery and Women's Health 2Healthgrades Recognizes Top Hospitals in Treatment of Maternity Care, Gynecologic Surgery and Women's Health 3Healthgrades Recognizes Top Hospitals in Treatment of Maternity Care, Gynecologic Surgery and Women's Health 4
... Reportlinker.com announces that a new market research ... The Global Pharmaceutical Fine Chemicals ... http://www.reportlinker.com/p0535967/The-Global-Pharmaceutical-Fine-Chemicals-Market-Outlook-to-2015.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Chemical_and_Material Introduction ... comprehensive overview of the global pharmaceutical fine ...
... SAN DIEGO, Oct. 18, 2011 Halozyme Therapeutics, ... company developing and commercializing products targeting the ... and drug delivery markets, today announced that the ... that women with HER2-positive early breast cancer who ...
Cached Medicine Technology:The Global Pharmaceutical Fine Chemicals Market Outlook to 2015 2The Global Pharmaceutical Fine Chemicals Market Outlook to 2015 3The Global Pharmaceutical Fine Chemicals Market Outlook to 2015 4The Global Pharmaceutical Fine Chemicals Market Outlook to 2015 5Halozyme Announces Positive Results from Roche's Subcutaneous Herceptin Phase 3 Trial 2Halozyme Announces Positive Results from Roche's Subcutaneous Herceptin Phase 3 Trial 3Halozyme Announces Positive Results from Roche's Subcutaneous Herceptin Phase 3 Trial 4
(Date:6/18/2013)... Lauren Sciences, a privately-held biotechnology company furthering development ... today that it was independently recognized as a ... Platform, and selected as a Featured Company, in ... , The report, " Early Stage Drug Delivery ... features companies MCD Group independently selected as technology ...
(Date:6/18/2013)... Case Medical Center enrolled their first patients in the ... novel, less-invasive procedure to help clear blockages in carotid ... than 300,000 people in the United States are diagnosed ... left untreated, these blockages can slow or even stop ... stroke, also known as a "brain attack." , ...
(Date:6/18/2013)... scrambling to gather data for the FDA to support ... injury in the United States. The University of Rochester ... the Journal of Neurotrauma that it might ... of one., Jeffrey J. Bazarian, M.D., M.P.H., an associate ... first to show that measuring a combination of two ...
(Date:6/18/2013)... first computer guided fitness training system using a ... three winners of the LeWeb,13 London Startup Competition, ... The startup company, Genetrainer, building on University of ... Ralph Pethica and Julian Gough, Professor of Bioinformatics ... selected from over 350 startups to be one ...
(Date:6/18/2013)... York, Pennsylvania (PRWEB) June 18, 2013 Two ... which unfurled in Philadelphia, Pennsylvania. As reported by ... dead in Philadelphia building collapse, 13 injured," a building scheduled ... in a nearby shop, and six of those persons succumbed ... the state and the country. , The situation should serve ...
Breaking Medicine News(10 mins):Health News:UH Case Medical Center among first to enroll patients for global carotid artery trial 2Health News:Ensuring The Safety of Pennsylvania Worksites 2Health News:Ensuring The Safety of Pennsylvania Worksites 3
... due to the combination of just two genes, according to a ... the Journal of Clinical Endocrinology and Metabolism this week,// identifies one ... contributors to height in men. These genes may also help explain ... tall version of both of these genes you will be taller ...
... ribozyme, an enzyme that can be used to kill the deadly ... had been designed using the viral clones and would kill the ... efficacy of the ribozyme was being tested on animals. The cloned ... presence of Hepatitis E virus. , , ...
... fruits and vegetables, but don't forget whole grains, if ... disease and cancer, researchers say.// Fruits and vegetables especially ... risk by about 32%. , According to a study ... of two to three slices of whole-grain bread each day were ...
... Hopkins University have found that treadmill testing is a ... problems. Many people who develop// heart disease have no ... researchers, treadmill testing can show up hidden weaknesses long ... a study of nearly 2,000 men and 3,000 women ...
... research involves a drug called zoledronic acid, which is approved ... which calcium seeps from the bones. The drug was found ... density, and the effect persisted for at least a year ... blood.// ,It will be about five years before doctors ...
... new recommendations telling pediatricians to screen all children for ... serious illness. Children who snore loudly may// suffer from ... can lead to growth, heart and pulmonary problems. ... older than age 1, the pediatricians' group urges doctors ...
Cached Medicine News:
Lumicon 48 mm red filter....
Heavy duty, all purpose illuminator available in blue and green. Unique Clip Switch automatically turns off when returned to pocket. Pre-focused lens tip Heine XHL Halogen bulb for bright, concentra...
... child-friendly vision test that's ... just seconds. Welch Allyn ... objective, accurate vision test ... detection of refractive error, ...
... Classic is a black and ... use by people who have ... picture control selector, the Classic ... high-contrast black text on a ...
Medicine Products: